Cytogel Pharma
Darien, US · Connecticut LLC
Founders & leadership
CD
C. Dean MaglarisExecutive
TM
Theodore MaioneDr. Maione is the Issuer's Chief Scientific Officer.
FW
Frederick W. TellingExecutive
JJ
Joseph J. RucciExecutive
Board
EB
E. Bulkeley GirswoldBoard director
MU
Michael UllmannBoard director
CK
Cassandra KlimpBoard director
EL
Eric LangBoard director
JP
Jerry P. LeamonBoard director
SC
Steven ChrustBoard director
AA
Aniello A. BiancoBoard director
EB
E. Bulkeley GriswoldBoard director
Reported raises · per SEC filings
Form D private placements$6M disclosed across 7 of 8 rounds · 2014–2025
▶$16MofferedMar 2026 · PharmaceuticalsRule 506(b)
▶$16MofferedMar 2026 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- C. Dean MaglarisExecutive Officer, Director
- Michael UllmannDirector
- Jerry P. LeamonDirector
- Theodore MaioneExecutive Officer
- Steven ChrustDirector
- Eric LangDirector
- Frederick W. TellingExecutive Officer, Director
- Cassandra KlimpDirector
- Offering amount
- $16M
- Minimum investment
- $50K
- Sales commissions
- $1.1M
- Proceeds to insiders
- $180K
- Placement agents
- XMS Capital Partners, LLC, FDX Capital LLC
- First sale
- Oct 2025
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$1.8MraisedOct 2024 · 18 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedOct 2024 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- C. Dean MaglarisExecutive Officer, Director
- Theodore MaioneExecutive Officer
- Michael UllmannDirector
- Frederick W. TellingExecutive Officer, Director
- Cassandra KlimpDirector
- Eric LangDirector
- Jerry P. LeamonDirector
- Steven ChrustDirector
- Offering amount
- $2.2M
- Amount sold
- $1.8M
- Proceeds to insiders
- $175K
- First sale
- Jun 2023
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$50KraisedJul 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$50KraisedJul 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- C. Dean MaglarisExecutive Officer, Director
- Cassandra KlimpDirector
- Frederick W. TellingDirector
- Steven ChrustDirector
- William M. CarelloExecutive Officer, Director
- Theodore MaioneExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Jun 2022
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$956.9KraisedMay 2021 · 12 investors · PharmaceuticalsRule 506(b)
▶$956.9KraisedMay 2021 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven ChrustDirector
- Theodore MaioneExecutive Officer
- William M. CarelloExecutive Officer, Director
- C. Dean MaglarisExecutive Officer, Director
- Cassandra KlimpDirector
- Frederick W. TellingDirector
- Offering amount
- $25M
- Amount sold
- $956.9K
- Sales commissions
- $1M
- Placement agents
- BCW Securities, LLC
- First sale
- Sep 2019
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$100KraisedMar 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$100KraisedMar 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven ChrustDirector
- C. Dean MaglarisExecutive Officer, Director
- Cassandra KlimpDirector
- Alan DuntonDirector
- Joseph J. RucciExecutive Officer, Director
- Frederick W. TellingDirector
- Theodore MaioneExecutive Officer
- Offering amount
- $200K
- Amount sold
- $100K
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$161.8KraisedMay 2018 · 5 investors · PharmaceuticalsRule 506(b)
▶$161.8KraisedMay 2018 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frederick W. TellingDirector
- Theodore MaioneExecutive Officer
- E. Bulkeley GriwoldDirector
- Joseph J. RucciExecutive Officer, Director
- Cassandra KlimpDirector
- C. Dean MaglarisExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $161.8K
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$2.7MraisedJan 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedJan 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Theodore MaioneExecutive Officer
- Frederick W. TellingDirector
- C. Dean MaglarisExecutive Officer, Director
- Joseph J. RucciExecutive Officer, Director
- E. Bulkeley GirswoldDirector
- Offering amount
- $8M
- Amount sold
- $2.7M
- First sale
- Jan 2015
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$240KraisedMar 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$240KraisedMar 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- C. Dean MaglarisExecutive Officer, Director
- Aniello A. BiancoDirector
- Theodore MaioneExecutive Officer
- Joseph J. RucciExecutive Officer, Director
- E. Bulkeley GriswoldDirector
- Offering amount
- $1.1M
- Amount sold
- $240K
- First sale
- Mar 2014
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cytogel Pharma raised?
- Cytogel Pharma has disclosed $6M raised across 7 of its 8 known rounds.
- Where is Cytogel Pharma headquartered?
- Cytogel Pharma is headquartered in Darien, US.